Abbott Laboratories
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $3.20B | $2.08B | $1.12B | $310.0M |
| FY2017 | $5.57B | $4.44B | $1.14B | $406.0M |
| FY2018 | $6.30B | $4.91B | $1.39B | $477.0M |
| FY2019 | $6.14B | $4.50B | $1.64B | $519.0M |
| FY2020 | $7.90B | $5.72B | $2.18B | $546.0M |
| FY2021 | $10.53B | $8.65B | $1.89B | $640.0M |
| FY2022 | $9.58B | $7.80B | $1.78B | $685.0M |
| FY2023 | $7.26B | $5.06B | $2.20B | $644.0M |
| FY2024 | $8.56B | $6.35B | $2.21B | $673.0M |
| FY2025 | $9.57B | $7.40B | $2.17B | $664.0M |